Whitegate Investment Counselors’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,500
Closed -$224K 66
2021
Q4
$224K Sell
4,500
-4,500
-50% -$237K 0.07% 59
2021
Q3
$414K Hold
9,000
0.06% 173
2021
Q2
$269K Buy
+9,000
New +$184K 0.04% 195
2019
Q1
Sell
-15,000
Closed -$32K 199
2018
Q4
$32K Sell
15,000
-14,000
-48% -$47.4K 0.01% 189
2018
Q3
$133K Hold
29,000
0.03% 163
2018
Q2
$142K Hold
29,000
0.03% 184
2018
Q1
$124K Buy
+29,000
New +$137K 0.03% 184

Other funds holding ASPN

Whitegate Investment Counselors's ASPN Position: Q1 2022 in Review

Whitegate Investment Counselors sold out of Aspen Aerogels (ASPN) in Q1 2022, closing a stake of 4,500 shares — an estimated $224K sold.

Whitegate Investment Counselors first reported a position in ASPN in Q1 2018 and held it in 7 quarters. The position peaked at $414K in Q3 2021. 145 funds tracked by Wall St. Rank hold ASPN as of Q1 2022.

  • Whitegate Investment Counselors reported no remaining Aspen Aerogels position as of Q1 2022 after selling out during the quarter.
  • Whitegate Investment Counselors sold 4,500 Aspen Aerogels shares in Q1 2022, an estimated $224K.
  • Whitegate Investment Counselors first reported a position in Aspen Aerogels in Q1 2018 and held it in 7 quarters.
  • Whitegate Investment Counselors's Aspen Aerogels position peaked at $414K in Q3 2021.
  • 145 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2022.

Based on Whitegate Investment Counselors's 13F filing for Q1 2022, filed 3 May 2022.